Exxon Mobil (XOM) Shareholder Segment Wealth Management Has Decreased Stake as Share Value Declined; American Capital Management Cut Its Gilead Sciences (GILD) Stake by $363,165; Share Value Rose

May 26, 2018 - By Adrian Mccoy

Exxon Mobil Corporation (NYSE:XOM) Logo

American Capital Management Inc decreased its stake in Gilead Sciences (GILD) by 12.93% based on its latest 2017Q4 regulatory filing with the SEC. American Capital Management Inc sold 5,115 shares as the company’s stock rose 1.93% while stock markets declined. The institutional investor held 34,431 shares of the health care company at the end of 2017Q4, valued at $2.47M, down from 39,546 at the end of the previous reported quarter. American Capital Management Inc who had been investing in Gilead Sciences for a number of months, seems to be less bullish one the $87.61B market cap company. The stock decreased 0.22% or $0.15 during the last trading session, reaching $67.38. About 3.96M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since May 26, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Segment Wealth Management Llc decreased its stake in Exxon Mobil Corp (XOM) by 9.48% based on its latest 2017Q4 regulatory filing with the SEC. Segment Wealth Management Llc sold 8,422 shares as the company’s stock declined 12.23% with the market. The institutional investor held 80,431 shares of the integrated oil company at the end of 2017Q4, valued at $6.73 million, down from 88,853 at the end of the previous reported quarter. Segment Wealth Management Llc who had been investing in Exxon Mobil Corp for a number of months, seems to be less bullish one the $333.25 billion market cap company. The stock decreased 1.94% or $1.56 during the last trading session, reaching $78.71. About 14.56 million shares traded. Exxon Mobil Corporation (NYSE:XOM) has declined 9.29% since May 26, 2017 and is downtrending. It has underperformed by 20.84% the S&P500.

Among 26 analysts covering Exxon Mobil (NYSE:XOM), 10 have Buy rating, 5 Sell and 11 Hold. Therefore 38% are positive. Exxon Mobil had 95 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was upgraded by UBS on Wednesday, September 6 to “Neutral”. Jefferies maintained Exxon Mobil Corporation (NYSE:XOM) rating on Tuesday, October 3. Jefferies has “Hold” rating and $81.0 target. Cowen & Co maintained Exxon Mobil Corporation (NYSE:XOM) rating on Tuesday, October 24. Cowen & Co has “Buy” rating and $100.0 target. As per Tuesday, January 23, the company rating was maintained by Piper Jaffray. The rating was maintained by Piper Jaffray on Tuesday, November 21 with “Hold”. The stock of Exxon Mobil Corporation (NYSE:XOM) has “Underweight” rating given on Thursday, September 3 by Barclays Capital. Barclays Capital upgraded Exxon Mobil Corporation (NYSE:XOM) on Monday, October 12 to “Equal-Weight” rating. Jefferies maintained Exxon Mobil Corporation (NYSE:XOM) rating on Friday, April 7. Jefferies has “Neutral” rating and $92 target. The firm earned “Overweight” rating on Tuesday, July 11 by Barclays Capital. RBC Capital Markets maintained the shares of XOM in report on Thursday, July 20 with “Hold” rating.

More notable recent Exxon Mobil Corporation (NYSE:XOM) news were published by: Seekingalpha.com which released: “Exxon Stock Isn’t So Slick” on May 01, 2018, also Seekingalpha.com with their article: “Exxon Mobil Becomes A Political Battleground” published on May 25, 2018, Seekingalpha.com published: “ExxonMobil: Sometimes The Turtle Beats The Hare” on May 22, 2018. More interesting news about Exxon Mobil Corporation (NYSE:XOM) were released by: Seekingalpha.com and their article: “Exxon: Is The Bottom In?” published on May 04, 2018 as well as Seekingalpha.com‘s news article titled: “Exxon Loses An Enemy” with publication date: May 08, 2018.

Investors sentiment decreased to 0.84 in Q4 2017. Its down 0.01, from 0.85 in 2017Q3. It dived, as 48 investors sold XOM shares while 819 reduced holdings. 123 funds opened positions while 603 raised stakes. 2.17 billion shares or 1.92% more from 2.13 billion shares in 2017Q3 were reported. The Massachusetts-based Kidder Stephen W has invested 2.08% in Exxon Mobil Corporation (NYSE:XOM). Ingalls And Snyder Ltd Liability owns 318,998 shares. Regal Investment Advsrs Ltd Liability invested in 0.75% or 40,395 shares. Moreover, Fernwood Invest Ltd has 1.08% invested in Exxon Mobil Corporation (NYSE:XOM). 28,446 are owned by Timber Creek Management Ltd Liability Company. Van Hulzen Asset Mgmt Limited Liability Corp accumulated 97,169 shares or 2.47% of the stock. Alexandria Limited Liability Company has invested 0.6% of its portfolio in Exxon Mobil Corporation (NYSE:XOM). Great West Life Assurance Communication Can, a Manitoba – Canada-based fund reported 5.17M shares. Endurance Wealth Mngmt Inc invested in 110,347 shares. Independent Order Of Foresters reported 2,185 shares. Villere St Denis J & Co Ltd Liability Corp invested in 12,189 shares. Lawson Kroeker Invest Mngmt Ne has 0.97% invested in Exxon Mobil Corporation (NYSE:XOM). Two Sigma Securities Limited Liability Company invested 0.05% in Exxon Mobil Corporation (NYSE:XOM). Clearbridge Ltd Llc accumulated 6.88 million shares. 4,350 are owned by De Burlo Gru.

Since December 11, 2017, it had 0 buys, and 4 selling transactions for $3.42 million activity. Shares for $200,293 were sold by Wascom Dennis G. On Monday, December 11 Corson Bradley W sold $1.62M worth of Exxon Mobil Corporation (NYSE:XOM) or 19,500 shares. Chapman Neil A sold $996,628 worth of stock.

Segment Wealth Management Llc, which manages about $425.00M and $413.72 million US Long portfolio, upped its stake in First Tr Exchange Traded Fd (FIW) by 19,565 shares to 33,805 shares, valued at $1.65 million in 2017Q4, according to the filing. It also increased its holding in First Tr Exchange Traded Fd (FDN) by 9,195 shares in the quarter, for a total of 15,736 shares, and has risen its stake in Ishares Tr (IWR).

Analysts await Exxon Mobil Corporation (NYSE:XOM) to report earnings on July, 27. They expect $1.16 earnings per share, up 48.72% or $0.38 from last year’s $0.78 per share. XOM’s profit will be $4.91 billion for 16.96 P/E if the $1.16 EPS becomes a reality. After $1.09 actual earnings per share reported by Exxon Mobil Corporation for the previous quarter, Wall Street now forecasts 6.42% EPS growth.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 130 analyst reports since July 29, 2015 according to SRatingsIntel. As per Monday, October 3, the company rating was maintained by RBC Capital Markets. Jefferies maintained it with “Hold” rating and $97 target in Tuesday, March 15 report. Credit Suisse maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Wednesday, March 23. Credit Suisse has “Outperform” rating and $116 target. The firm earned “Buy” rating on Wednesday, November 8 by Mizuho. The firm has “Buy” rating by William Blair given on Thursday, August 31. The rating was maintained by Credit Suisse on Wednesday, September 14 with “Outperform”. Berenberg initiated Gilead Sciences, Inc. (NASDAQ:GILD) on Thursday, September 22 with “Buy” rating. The firm has “Buy” rating by William Blair given on Wednesday, June 14. The stock has “Strong Buy” rating by Jyske Bank on Thursday, September 10. As per Wednesday, May 2, the company rating was maintained by Barclays Capital.

Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.23, from 1.03 in 2017Q3. It dropped, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. Commonwealth Bancorporation Of Australia holds 0.21% or 305,009 shares in its portfolio. Blackrock Inc, a New York-based fund reported 103.80M shares. 278,035 were accumulated by Fort Ltd Partnership. Macguire Cheswick & Tuttle Invest Counsel Ltd Llc holds 26,726 shares or 0.35% of its portfolio. Ruffer Limited Liability Partnership invested in 13,394 shares. Lockheed Martin Invest Mgmt Co, a Maryland-based fund reported 5,000 shares. Burns J W And New York stated it has 26,666 shares or 0.48% of all its holdings. 494 were reported by Motco. Panagora Asset Mngmt Inc owns 0.28% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 1.04 million shares. Muhlenkamp & stated it has 4.67% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Selway Asset invested in 19,650 shares or 0.83% of the stock. Markel Corp holds 0.04% or 33,000 shares. Ims Management invested in 0.67% or 15,211 shares. Aviva Pcl holds 0.34% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 839,748 shares. Meiji Yasuda Life Ins Co holds 41,458 shares.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Seekingalpha.com which released: “Gilead Sciences (GILD) Presents at Bank of America Merrill Lynch 2018 Healthcare Conference (Transcript)” on May 16, 2018, also Bizjournals.com with their article: “He helped Gilead score billions from HIV, hepatitis C drugs — now he’s building a cancer fighter” published on May 23, 2018, Seekingalpha.com published: “Gilead: Novartis’s Kymriah Is Coming To America” on May 24, 2018. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: 247Wallst.com and their article: “Analysts Show More Caution Toward Gilead’s Mystical Recovery” published on May 02, 2018 as well as Seekingalpha.com‘s news article titled: “Gilead: What A Disaster” with publication date: May 08, 2018.

American Capital Management Inc, which manages about $1.67B US Long portfolio, upped its stake in Factset Research System (NYSE:FDS) by 3,404 shares to 284,253 shares, valued at $54.79M in 2017Q4, according to the filing. It also increased its holding in Aerovironment (NASDAQ:AVAV) by 127,619 shares in the quarter, for a total of 1.44 million shares, and has risen its stake in Idexx Laboratories (NASDAQ:IDXX).

Since January 2, 2018, it had 0 insider purchases, and 22 sales for $44.80 million activity. 5,833 shares valued at $467,138 were sold by Cogan John Francis on Friday, March 16. Another trade for 100,000 shares valued at $8.02M was made by Meyers James R on Tuesday, January 16. 50,000 shares were sold by MARTIN JOHN C, worth $3.68M. $4.68 million worth of stock was sold by WILSON GAYLE E on Friday, February 9. $401,566 worth of Gilead Sciences, Inc. (NASDAQ:GILD) was sold by Washington Robin L on Wednesday, February 21.

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>